BSX Boston Scientific Corp

  1. Stocks
  2. Healthcare
  3. NYSE: BSX

Price (delayed)

$44.245

Market cap

$64.13B

P/E Ratio

18.59

Dividend/share

N/A

EPS

$2.38

Enterprise value

$75.48B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 83

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance ...

Highlights
The P/E is 70% below the 5-year quarterly average of 63.0 and 31% below the last 4 quarters average of 27.5
The equity has grown by 10% YoY and by 2.8% from the previous quarter
The EPS has increased by 26% YoY but it has decreased by 4.4% from the previous quarter
Boston Scientific's net income has increased by 25% YoY but it has decreased by 4.7% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.bostonscientific.com
Peers: EW SYK MMSI MDT

Key stats

What are the main financial stats of BSX

BSX stock price

How has the Boston Scientific stock price performed over time
Intraday
-1.96%
1 week
-0.88%
1 month
0.92%
1 year
-57.51%
YTD
-53.6%
QTD
1.36%

Financial performance

How have Boston Scientific's revenue and profit performed over time
Revenue
$21.07B
Gross profit
$14.57B
Operating income
$3.93B
Net income
$3.5B
Gross margin
69.1%
Net margin
16.6%
Boston Scientific's net income has increased by 25% YoY but it has decreased by 4.7% QoQ
Boston Scientific's net margin has increased by 15% YoY but it has decreased by 5% QoQ
Boston Scientific's operating income has increased by 13% YoY but it has decreased by 5% from the previous quarter
Boston Scientific's gross profit has increased by 10% YoY

Price vs fundamentals

How does BSX's price correlate with its fundamentals

Growth

What is Boston Scientific's growth rate over time

Valuation

What is Boston Scientific stock price valuation
BSX P/E details
P/E
18.59
P/B
2.5
P/S
3.04
EV/EBIT
18.68
EV/EBITDA
13.79
EV/Sales
3.58
The P/E is 70% below the 5-year quarterly average of 63.0 and 31% below the last 4 quarters average of 27.5
The EPS has increased by 26% YoY but it has decreased by 4.4% from the previous quarter
The stock's price to book (P/B) is 45% less than its 5-year quarterly average of 4.6 and 29% less than its last 4 quarters average of 3.6
The equity has grown by 10% YoY and by 2.8% from the previous quarter
BSX's P/S is 48% below its 5-year quarterly average of 6.0 and 30% below its last 4 quarters average of 4.4
The revenue has increased by 9% YoY

Efficiency

How efficient is Boston Scientific business performance
The return on assets has grown by 15% year-on-year but it has declined by 7% since the previous quarter
The return on equity has increased by 12% year-on-year but it has declined by 7% since the previous quarter
BSX's ROIC is down by 7% from the previous quarter
The ROS has decreased by 4.5% from the previous quarter but it has increased by 2.7% YoY

Dividends

What is BSX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BSX.

Financial health

How did Boston Scientific financials performed over time
Boston Scientific's total assets is 132% more than its total liabilities
BSX's quick ratio is down by 19% year-on-year but it is up by 11% since the previous quarter
BSX's current ratio is down by 10% year-on-year but it is up by 10% since the previous quarter
Boston Scientific's debt is 53% lower than its equity
The equity has grown by 10% YoY and by 2.8% from the previous quarter
Boston Scientific's debt to equity has decreased by 8% from the previous quarter and by 6% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.